NCT06144671 - GT201 Injection For The Treatment Of Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

September 13, 2026

Study Completion Date

September 13, 2026

Conditions

Solid Tumor, Adult

Interventions

DRUG

GT201

Autologous tumor infiltrating lymphocyte injection

Trial Locations (4)

RECRUITING

West China Hospital Sichuan University, Chengdu

RECRUITING

The fifth medical center of the General Hospital of the Chinese people's Liberation Army, Beijing

RECRUITING

Union Hospital Tongji Medical College Huazhong University Of Science And Technology, Wuhan

RECRUITING

Shandong Cancer Hospital, Jinan